Researchers at the University of Alberta in Canada reported a case of porphyria cutanea tarda that presented with rare…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
A newly identified mutation in the HMBS gene was found to be linked to acute intermittent porphyria in a patient…
Relapses are more frequent among porphyria cutanea tarda patients who had previously achieved remission with antimalarial medications, a study…
Investigative drug candidate givosiran significantly reduced porphyria attacks in two clinical trials, according to a recent presentation at the…
The diagnosis of porphyria often is delayed, which highlights the need for increased awareness among clinical physicians. A case report…